PharmaMar to submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Hossein Borghaei, MD discusses the recent data released and advantages and potential limitations of the new drug.
Hossein Borghaei, DO, MS – New Drug Application (NDA) for lurbinectedin
